Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy

The codon adaptation index-a measure of directional synonymous codon usage bias, and its potential applications

Sharp, P. M., & Li, W.-H. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.3.1281 · Cited by 3,992

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728

eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation

Gingras, A., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,103

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Caput, D., Beutler, B., Hartog, K., Thayer, R. M., Brown-Shimer, S. L., & Cerami, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1670 · Cited by 1,504

P bodies and the control of mRNA translation and degradation

Parker, R., & Sheth, U. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.011 · Cited by 1,335

The highways and byways of mRNA decay

Garneau, N. L., Wilusz, J., & Wilusz, C. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2104 · Cited by 1,294

Dendritic cells as therapeutic vaccines against cancer

Banchereau, J., & Palucka, A. K. (2005) · Nature reviews. Immunology · doi:10.1038/nri1592 · Cited by 1,217

Regulating the fate of mRNA: the control of cellular iron metabolism

Klausner, R. D., Rouault, T. A., & Harford, J. B. (1993) · Cell · doi:10.1016/0092-8674(93)90046-s · Cited by 1,210

mRNA is an endogenous ligand for toll-like receptor 3

Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062

CRISPR/Cas9 therapeutics: progress and prospects

Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., He, X., Liu, M., Li, P., & Yu, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01309-7 · Cited by 824

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601

Polymeric Delivery of Therapeutic Nucleic Acids

Kumar, R., Chalarca, C. F. S., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 379

Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery

Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2019) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 259

Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA

Patel, S., Ashwanikumar, N., Robinson, E., DuRoss, A., Sun, C., Murphy-Benenato, K. E., Mihai, C., Almarsson, Ö., & Sahay, G. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b02664 · Cited by 251

Mechanism of action of mRNA-based vaccines

Iavarone, C., O’hagan, D. T., Yu, D., Delahaye, N. F., & Ulmer, J. B. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1355245 · Cited by 234

Paving the Road for RNA Therapeutics

Dammes, N., & Peer, D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.004 · Cited by 223

Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine

Kwon, H., Kim, M., Seo, Y., Moon, Y. S., Lee, H. J., Lee, K., & Lee, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.034 · Cited by 208

MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct

Jain, R., Frederick, J. P., Huang, E. Y., Burke, K. E., Mauger, D. M., Andrianova, E. A., Farlow, S. J., Siddiqui, S., Pimentel, J., Cheung-Ong, K., et al. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0734 · Cited by 164

Peripheral Nerve Injury: Current Challenges, Conventional Treatment Approaches, and New Trends in Biomaterials-Based Regenerative Strategies

López‐Cebral, R., Silva‐Correia, J., Reis, R. L., Silva, T. H., & Oliveira, J. M. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00655 · Cited by 141

Biomedical applications of mRNA nanomedicine

Xiong, Q., Lee, G. Y., Ding, J., Li, W., & Shi, J. (2018) · Nano Research · doi:10.1007/s12274-018-2146-1 · Cited by 125

Endocytic Profiling of Cancer Cell Models Reveals Critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression

Sayers, E. J., Peel, S. E., Schantz, A., England, R., Beano, M., Bates, S. M., Desai, A. S., Puri, S., Ashford, M. B., & Jones, A. T. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.07.018 · Cited by 119

RNA interfering molecule delivery from in situ forming biodegradable hydrogels for enhancement of bone formation in rat calvarial bone defects

Nguyen, M. K., Jeon, O., Dang, P. N., Huynh, C. T., Varghai, D., Riazi, H., McMillan, A., Herberg, S., & Alsberg, E. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.06.007 · Cited by 110

An overview of rational design of mRNA-based therapeutics and vaccines

To, K. K. W., & Cho, W. C. S. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1935859 · Cited by 110

Inhaled RNA Therapy: From Promise to Reality

Chow, M. Y. T., Qiu, Y., & Lam, J. K. W. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.002 · Cited by 105

TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals

Manfredi, F., Cianciotti, B. C., Potenza, A., Tassi, E., Noviello, M., Biondi, A., Ciceri, F., Bonini, C., & Ruggiero, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01689 · Cited by 108

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

Leal, L., Guardo, A. C., Morón‐López, S., Salgado, M., Mothe, B., Heirman, C., Pannus, P., Vanham, G., van den Ham, H., Gruters, R. A., et al. (2018) · AIDS · doi:10.1097/qad.0000000000002026 · Cited by 102

Gene therapy to enhance angiogenesis in chronic wounds

Shaabani, E., Sharifiaghdam, M., Majidi, R. F., Smedt, S. C. D., Braeckmans, K., & Fraire, J. C. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.020 · Cited by 102

mRNA Polyplexes with Post-Conjugated GALA Peptides Efficiently Target, Transfect, and Activate Antigen Presenting Cells

Lou, B., Koker, S. D., Lau, C. Y. J., Hennink, W. E., & Mastrobattista, E. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00524 · Cited by 92

Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin

Golombek, S., Pilz, M., Steinle, H., Kochba, E., Levin, Y., Lunter, D., Schlensak, C., Wendel, H. P., & Avci-Adali, M. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.03.005 · Cited by 88

Folate-Targeted mRNA Delivery Using Chitosan-Functionalized Selenium Nanoparticles: Potential in Cancer Immunotherapy

Maiyo, F., & Singh, M. (2019) · Pharmaceuticals · doi:10.3390/ph12040164 · Cited by 84

mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification

Moradian, H., Roch, T., Lendlein, A., & Gossen, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60506-4 · Cited by 77

Efficient delivery of VEGF-A mRNA for promoting diabetic wound healing via ionizable lipid nanoparticles

Zha, W., Wang, J., Guo, Z., Zhang, Y., Wang, Y., Dong, S., Liu, C., Xing, H., & Li, X. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122565 · Cited by 77

The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology

Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12584 · Cited by 72

In vitro evolution of enhanced RNA replicons for immunotherapy

Li, Y., Teague, B., Zhang, Y., Su, Z., Porter, E., Dobosh, B., Wagner, T., Irvine, D. J., & Weiss, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-43422-0 · Cited by 71

Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing

Youssef, M., Hitti, C., Fulber, J. P. C., & Kamen, A. (2023) · Biomolecules · doi:10.3390/biom13101497 · Cited by 63

Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy

Zhang, X., Men, K., Zhang, Y., Zhang, R., Yang, L., & Duan, X. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198747 · Cited by 57

Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines

Guevara, M. L., Persano, S., & Persano, F. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190619150221 · Cited by 57

Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models

Farzani, T. A., Földes, K., Ergünay, K., Gürdal, H., Baştuğ, A., & Özkul, A. (2019) · Vaccines · doi:10.3390/vaccines7030115 · Cited by 55

A scalable and robust cationic lipid/polymer hybrid nanoparticle platform for mRNA delivery

Meyer, R. A., Hussmann, G. P., Peterson, N. C., Santos, J. L., & Tuesca, A. D. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121314 · Cited by 57

Nanoparticles versus Dendritic Cells as Vehicles to Deliver mRNA Encoding Multiple Epitopes for Immunotherapy

Firdessa-Fite, R., & Creusot, R. J. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.10.015 · Cited by 53

Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics

de Vyver, T. V., Smedt, S. C. D., & Raemdonck, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114041 · Cited by 51

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development

Dezfouli, A. B., Yazdi, M., Pockley, A. G., Khosravi, M., Kobold, S., Wagner, E., & Multhoff, G. (2021) · Cells · doi:10.3390/cells10123390 · Cited by 53

Introduction to RNA Vaccines

Kramps, T., & Elbers, K. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_1 · Cited by 53

Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer

Levačić, A. K., Berger, S., Müller, J., Wegner, A., Lächelt, U., Dohmen, C., Rudolph, C., & Wagner, E. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.016 · Cited by 47

mRNA Vaccines: Why Is the Biology of Retroposition Ignored?

Domazet‐Lošo, T. (2022) · Genes · doi:10.3390/genes13050719 · Cited by 47

Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges

Du, R., Wang, C., Zhu, L., & Yang, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102236 · Cited by 45

Hepatocellular-Targeted mRNA Delivery Using Functionalized Selenium Nanoparticles In Vitro

Singh, D., & Singh, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030298 · Cited by 45

Bioinspired cellular membrane-derived vesicles for mRNA delivery

Xu, X., Xu, L., Wang, J., Wen, C., Xia, J., Zhang, Y., & Liang, Y. (2024) · Theranostics · doi:10.7150/thno.93755 · Cited by 43

Non-coding RNA delivery for bone tissue engineering: Progress, challenges, and potential solutions

Guan, S., Zhang, Z., & Wu, J. (2022) · iScience · doi:10.1016/j.isci.2022.104807 · Cited by 40

Cancer Vaccines in the Immunotherapy Era: Promise and Potential

Verma, C., Pawar, V. A., Srivastava, S., Tyagi, A., Kaushik, G., Shukla, S. K., & Kumar, V. (2023) · Vaccines · doi:10.3390/vaccines11121783 · Cited by 40

RNA ‐based therapies for genodermatoses

Bornert, O., Peking, P., Bremer, J., Koller, U., van den Akker, P. C., Aartsma-Rus, A. M., Pasmooij, A. M. G., Murauer, E. M., & Nyström, A. (2016) · Experimental Dermatology · doi:10.1111/exd.13141 · Cited by 37

Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules

Zhang, J., Liu, Y., Li, C., Xiao, Q., Zhang, D., Chen, Y., Rosenecker, J., Ding, X., & Guan, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092182 · Cited by 39

Delivery of mRNA vaccines and anti-PDL1 siRNA through non-invasive transcutaneous route effectively inhibits tumor growth

Wang, K., Wang, X., Jiang, D. M., Pei, Y., Wang, Z., Zhou, X., Wu, J., Mo, X., & Wang, H. (2022) · Composites Part B Engineering · doi:10.1016/j.compositesb.2022.109648 · Cited by 35

Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials

Karimi-Sani, I., Molavi, Z., Naderi, S., Mirmajidi, S. H., Zare, I., Naeimzadeh, Y., Mansouri, A., Tajbakhsh, A., Savardashtaki, A., & Sahebkar, A. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02882-x · Cited by 39

Antibody‐Functionalized Gold Nanostar‐Mediated On‐Resonance Picosecond Laser Optoporation for Targeted Delivery of RNA Therapeutics

Kafshgari, M. H., Agiotis, L., Largillière, I., Patskovsky, S., & Michel Meunier, A. (2021) · Small · doi:10.1002/smll.202007577 · Cited by 31

Overexpression of VLA-4 in glial-restricted precursors enhances their endothelial docking and induces diapedesis in a mouse stroke model

Jabłońska, A., Shea, D. J., Cao, S., Bulte, J. W. M., Janowski, M., Κωνσταντόπουλος, Κ., & Walczak, P. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17703888 · Cited by 32

Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy

Lee, M., Lee, M.-J., Song, Y., Kim, S., & Park, N. (2024) · Molecules · doi:10.3390/molecules29194737 · Cited by 31

Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm

Beigi, A., Naghib, S. M., Matini, A., Tajabadi, M., & Mozafari, M. R. (2024) · Current Gene Therapy · doi:10.2174/0115665232292768240503050508 · Cited by 30

Controlled Non‐Viral Gene Delivery in Cartilage and Bone Repair: Current Strategies and Future Directions

Gonzalez‐Fernandez, T., Kelly, D. J., & O’Brien, F. J. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800038 · Cited by 30

Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System

Oliveira, A. C., Fernandes, J., Gonçalves, A., Gomes, A. C., & Oliveira, M. E. C. D. R. (2018) · Current Drug Targets · doi:10.2174/1389450119666180703145410 · Cited by 26

Development of an RNA Expression Platform Controlled by Viral Internal Ribosome Entry Sites

Ko, H. L., Park, H., Kim, J., Kim, H., Youn, H., & Nam, J. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1811.11019 · Cited by 23

Physical transfection technologies for macrophages and dendritic cells in immunotherapy

Harizaj, A., Smedt, S. C. D., Lentacker, I., & Braeckmans, K. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1828340 · Cited by 21

mRNA Vaccine Platform: mRNA Production and Delivery

Litvinova, V. R., Рудометов, А. П., Карпенко, Л. И., & Ilyichev, A. A. (2023) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162023020152 · Cited by 26

Lipid nanoparticles-loaded with toxin mRNA represents a new strategy for the treatment of solid tumors

Granot-Matok, Y., Ezra, A., Ramishetti, S., Sharma, P., Naidu, G. S., Benhar, I., & Peer, D. (2023) · Theranostics · doi:10.7150/thno.82228 · Cited by 20

Integrating Micro- and Nanostructured Platforms and Biological Drugs to Enhance Biomaterial-Based Bone Regeneration Strategies

Shah, S. A., Sohail, M. F., Nakielski, P., Rinoldi, C., Zargarian, S. S., Kosik‐Kozioł, A., Ziai, Y., Bayan, M. A. H., Zakrzewska, A., Rybak, D., et al. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c01133 · Cited by 22

Biomaterial scaffold-based gene delivery for the repair of complex wounds: Challenges, progress, and future perspectives

Chávez, J. C. P., McGrath, M., Kearney, C. J., Browne, S., & O’Brien, F. J. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100073 · Cited by 19

The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair

Chambers, P., Ziminska, M., Elkashif, A., Wilson, J., Redmond, J., Tzagiollari, A., Ferreira, C., Balouch, A. P., Bogle, J., Donahue, S. W., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.006 · Cited by 18

Transfection of hypoxia-inducible factor-1α mRNA upregulates the expression of genes encoding angiogenic growth factors

Włodarczyk, J., Leng, A., Abadchi, S. N., Shababi, N., Mokhtari‐Esbuie, F., Gheshlaghi, S., Ravari, M. R., Pippenger, E. K., Afrasiabi, A., Ha, J. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54941-w · Cited by 17

Keratinocyte Growth Factor Modified Messenger RNA Accelerating Cell Proliferation and Migration of Keratinocytes

Denzinger, M., Link, A., Kurz, J., Krauß, S., Thoma, R., Schlensak, C., Wendel, H. P., & Krajewski, S. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0737 · Cited by 17

Enhancing Chimeric Antigen Receptor T‐Cell Generation via Microfluidic Mechanoporation and Lipid Nanoparticles

Lim, J., Oh, D., Cheng, M., Chintapula, U. K., Liu, S., Reynolds, D., Zhang, X., Zhou, Y., Xu, X., & Ko, J. (2025) · Small · doi:10.1002/smll.202410975 · Cited by 16

mRNA therapeutics for disease therapy: principles, delivery, and clinical translation

Zhou, D., Wang, K., Zhang, Y., Ma, K., Yang, X., Li, Z.-Y., Yu, S., Chen, K., & Qiao, S. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02782h · Cited by 18

Interfacially Engineered Pyridinium Pseudogemini Surfactants as Versatile and Efficient Supramolecular Delivery Systems for DNA, siRNA, and mRNA

Satyal, U., Draghici, B., Dragic, L., Zhang, Q., Norris, K. W., Madesh, M., Brailoiu, E., & Ilies, M. A. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07066 · Cited by 15

Vectored gene delivery for lifetime animal contraception: Overview and hurdles to implementation

Hay, B. A., Li, J., & Guo, M. (2017) · Theriogenology · doi:10.1016/j.theriogenology.2017.11.003 · Cited by 15

Delivery strategies of RNA therapeutics to leukocytes

Tarab‐Ravski, D., Stotsky‐Oterin, L., & Peer, D. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.016 · Cited by 16

Plasmid DNA and mRNA delivery: Approaches and challenges

Singh, A. K., Goel, K., & Dhanawat, M. (2025) · Advances in immunology · doi:10.1016/bs.ai.2024.12.001 · Cited by 13

Context base editing for splice correction of IVSI-110 β-thalassemia

Naiisseh, B., Papasavva, P. L., Papaioannou, N. Y., Tomazou, M., Koniali, L., Felekis, X., Constantinou, C. G., Sitarou, M., Christou, S., Kleanthous, M., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102183 · Cited by 13

An insight of different classes of RNA-based therapeutic, nanodelivery and clinical status: Current landscape

Chatterjee, S., Bhattacharya, M., Lee, S., & Chakraborty, C. (2023) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2023.100150 · Cited by 12

Development of a Novel Polymer-Based mRNA Coating for Surgical Suture to Enhance Wound Healing

Link, A., Haag, H., Michel, T., Denzinger, M., Wendel, H. P., Schlensak, C., & Krajewski, S. (2019) · Coatings · doi:10.3390/coatings9060374 · Cited by 12

Smuggling on the Nanoscale—Fusogenic Liposomes Enable Efficient RNA-Transfer with Negligible Immune Response In Vitro and In Vivo

Hoffmann, M., Gerlach, S., Takamiya, M., Tarazi, S., Hersch, N., Csiszár, Á., Springer, R., Dreissen, G., Scharr, H., Rastegar, S., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041210 · Cited by 11

Self‐Organization of Iron Sulfide Nanoparticles into Complex Multicompartment Supraparticles

Emre, E. S. T., Emre, A. E., Vecchio, D. A., Kadiyala, U., VanEpps, J. S., & Kotov, N. A. (2023) · Advanced Materials · doi:10.1002/adma.202211244 · Cited by 12

Biodegradable Dendronized Polymers for Efficient mRNA Delivery

Oldenhuis, N. J., Eldredge, A. C., Burts, A. O., Ryu, K. A., Chung, J., Johnson, M. E., & Guan, Z. (2016) · ChemistrySelect · doi:10.1002/slct.201600939 · Cited by 10

Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation

Pal, S., Cannata, J. N., & Rouge, J. L. (2025) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5c00126 · Cited by 12

Prime editing in mammals: From promise to practicalities

Brooks, I. R., Graham, C., Kazemizadeh, A., & Jackow, J. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102719 · Cited by 8

Nano-formulations for bone-specific delivery of siRNA for CrkII silencing-induced regulation of bone formation and resorption to maximize therapeutic potential for bone-related diseases

Seong, S., Vijayan, V., Kim, J. H., Kim, K., Kim, I., Cherukula, K., Park, I., & Kim, N. (2023) · Biomaterials Science · doi:10.1039/d2bm02038f · Cited by 8

DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies

Анатольевич, Г. А., Savkina, M. V., Obukhov, Y. I., Меркулов, В. А., & Olefir, Y. V. (2019) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2019-19-2-72-80 · Cited by 8

Effects of Tissue Pressure on Transgene Expression Characteristics via Renal Local Administration Routes from Ureter or Renal Artery in the Rat Kidney

Oyama, N., Takahashi, H., Kawaguchi, M., Miyamoto, H., Nishida, K., Tsurumaru, M., Nakashima, M., Yamashita, F., Hashida, M., & Kawakami, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020114 · Cited by 8

Polymeric Vehicles for Nucleic Acid Delivery: Enhancing the Therapeutic Efficacy and Cellular Uptake

Gupta, P., Sharma, A., & Mittal, V. (2024) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/0126673878324536240805060143 · Cited by 7

Supramolecular Gene Transfection Agents

Pitard, B., & Habrant, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12563-6 · Cited by 8

Next-Generation Therapeutics: mRNA as a Novel Therapeutic Option for Single-Gene Disorders

Michel, T., Wendel, H.-P., & Krajewski, S. (2016) · InTech eBooks · doi:10.5772/62243 · Cited by 7

Payload‐Driven Design of Polymeric Carriers for Nucleic Acid Delivery: Insights from Structure–Function Relationships

Moradian, H., Dunne, C. M., Gossen, M., & Hartlieb, M. (2025) · Advanced Science · doi:10.1002/advs.202512653 · Cited by 6

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Michel, T., Link, A., Abraham, M.-K., Schlensak, C., Peter, K., Wendel, H.-P., Wang, X., & Krajewski, S. (2019) · Journal of Visualized Experiments · doi:10.3791/58444 · Cited by 7

Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route

Chen, F., Liu, Q., Xiong, Y., & Xu, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.984981 · Cited by 5

Gram‐Scale Chemical Synthesis of Base‐Modified Ribonucleoside‐5′‐O‐Triphosphates

Shanmugasundaram, M., Senthilvelan, A., & Kore, A. R. (2016) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/cpnc.20 · Cited by 4

Modeling the intracellular dynamics of the dengue viral infection and the innate immune response

Castaño-Arcila, M., Aguilera, L. U., & Rodríguez-González, J. (2020) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2020.110529 · Cited by 3

mRNA vaccines: Why and how they should be modified

Feliciello, I., & Procino, A. (2021) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2021.10072 · Cited by 3

TRAIL Therapy for Breast Cancer Treatment by Employing Lipopolymer mRNA Delivery

Thapa, B., Remant, K. C., Liu, X., Fu, W. E., Seol, D., & Uludağ, H. (2022) · GEN Biotechnology · doi:10.1089/genbio.2021.0007 · Cited by 4

Folate-functionalized chitosan nanoparticles: a versatile platform for targeted drug delivery and biomedical applications

Pareek, A., Modi, D., Kapoor, D. U., Prajapati, B. G., Fareed, M., & Alsaidan, O. A. (2026) · International Journal of Polymeric Materials · doi:10.1080/00914037.2025.2610712 · Cited by 3

Deconvolution of synthetic mRNA expression: Nucleoside chemistry alters translatability

Moradian, H., Schwestka, M., Roch, T., & Gossen, M. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10622 · Cited by 3

Key to Delivery: The (Epi-)genome Editing Vector Toolbox

Just, S., & Büning, H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7774-1_7 · Cited by 3

A systematic review on vaccine developmental approaches: Evaluating efficacy, and addressing challenges of infectious diseases in the post-COVID-19 era

Sithole, M. N., Khan, M. R., Mohammed, H. A., Khan, R. A., Naik, K., & Choonara, Y. E. (2026) · Virus Research · doi:10.1016/j.virusres.2026.199720 · Cited by 2

Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter

Butterfield, K., McGrath, P. S., Han, C. M., Kogut, I., & Bilousova, G. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0655-1_2 · Cited by 2

mRNA-Vaccine Platform: Features of Obtaining and Delivery of mRNA

Litvinova, V. R., Рудометов, А. П., Карпенко, Л. И., & Ilyichev, A. A. (2023) · Биоорганическая химия · doi:10.31857/s013234232302015x · Cited by 2

Blending Carbohydrate and Quinine-Based Polymers Imparts Colloidal Stability, Improved Performance, and Cell Specificity for mRNA Delivery

Kreofsky, N. W., Roy, P., Ghosh, R., Panda, S., Sarısözen, C., & Reineke, T. M. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c00901 · Cited by 1

mRNA nanotherapeutics for sepsis: immune modulation strategies and translational challenges

Liu, Y., Wang, K., Gao, F., Bai, X., Yang, J., Li, Z., & Wang, Y.-C. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04366-6 · Cited by 2

Co-formulation of IL-12 mRNA and doxorubicin in polymeric nanoparticles for simultaneous delivery in murine melanoma

Tanskanen, E., Sun, H., Cheng, K.-C., Ishihara, J., & Patel, A. K. (2026) · RSC Pharmaceutics · doi:10.1039/d6pm00136j · Cited by 1

Less is more: slow-codon windows enhance eGFP mRNA resilience against RNA interference

Müller, J., Schwake, G., Reiser, A., Woschée, D., Alirezaeizanjani, Z., Rädler, J. O., & Rudorf, S. (2025) · Journal of The Royal Society Interface · doi:10.1098/rsif.2024.0582

Gene Therapy in Cardiac Disease

Vakrou, S., & Malliaras, K. G. (2019) · Springer eBooks · doi:10.1007/978-3-319-98186-4_18

mRNA AŞILARINDA GÜNCEL YAKLAŞIMLAR

BATUR, K., & Yardımcı, H. (2022) · Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni · doi:10.38137/vftd.1021843

A stochastic model for hepatitis C viral infection dynamics with the innate immune response

Castaño-Arcila, M., & Rodríguez-González, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-32-390171-0.00018-4

Current prospects for mRNA gene delivery

Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.016 · Cited by 200

mRNA Modification and delivery strategies towards the establishment of a platform for safe and effective gene therapy

Andries, O. (2015) · Ghent University Academic Bibliography (Ghent University)

mRNA as gene therapeutic: How to control protein expression

Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232

Breakthroughs in mRNA modification and nanoparticle-based delivery vehicles facilitate gene therapy strategiesPreprint

Dowaidar, M. (2021) · doi:10.31219/osf.io/ky7dt · Cited by 2

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

Gómez-Aguado, I., Rodríguez-Castejón, J., Vicente-Pascual, M., Rodríguez‐Gascón, A., Solinís, M. Á., & del Pozo‐Rodríguez, A. (2020) · Nanomaterials · doi:10.3390/nano10020364 · Cited by 229